about
Stereoselective biodegradation of amphetamine and methamphetamine in river microcosmsMeasuring biomarkers in wastewater as a new source of epidemiological information: Current state and future perspectives.Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater.Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities.Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination.Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data. Part 1: Estimation of the usage of drugs in local communities.Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysisEnantiomer profiling of high loads of amphetamine and MDMA in communal sewage: a Dutch perspective.Liquid chromatography-tandem mass spectrometry determination of synthetic cathinones and phenethylamines in influent wastewater of eight European cities.Increased levels of the oxidative stress biomarker 8-iso-prostaglandin F2α in wastewater associated with tobacco useDevelopment of a filter to prevent infections with spore-forming bacteria in injecting drug users.Pharmacologically active compounds in the environment and their chirality.Critical evaluation of methodology commonly used in sample collection, storage and preparation for the analysis of pharmaceuticals and illicit drugs in surface water and wastewater by solid phase extraction and liquid chromatography-mass spectrometrIllicit and pharmaceutical drug consumption estimated via wastewater analysis. Part B: placing back-calculations in a formal statistical framework.A review on emerging contaminants in wastewaters and the environment: current knowledge, understudied areas and recommendations for future monitoring.A novel immobilization strategy for electrochemical detection of cancer biomarkers: DNA-directed immobilization of aptamer sensors for sensitive detection of prostate specific antigens.Community Sewage Sensors towards Evaluation of Drug Use Trends: Detection of Cocaine in Wastewater with DNA-Directed Immobilization Aptamer Sensors.New Analytical Framework for Verification of Biomarkers of Exposure to Chemicals Combining Human Biomonitoring and Water Fingerprinting.In Situ Calibration of a New Chemcatcher Configuration for the Determination of Polar Organic Micropollutants in Wastewater Effluent.Testing wastewater to detect illicit drugs: state of the art, potential and research needs.Wastewater-Based Epidemiology To Monitor Synthetic Cathinones Use in Different European Countries.New Framework To Diagnose the Direct Disposal of Prescribed Drugs in Wastewater - A Case Study of the Antidepressant Fluoxetine.Monitoring Genetic Population Biomarkers for Wastewater-Based Epidemiology.Estimation of caffeine intake from analysis of caffeine metabolites in wastewater.Wastewater-based epidemiology to assess pan-European pesticide exposure.Enantioselective degradation of amphetamine-like environmental micropollutants (amphetamine, methamphetamine, MDMA and MDA) in urban water.Enantiomeric profiling of a chemically diverse mixture of chiral pharmaceuticals in urban water.Enantiomeric profiling of chiral drug biomarkers in wastewater with the usage of chiral liquid chromatography coupled with tandem mass spectrometry.Feedback-amplified electrochemical dual-plate boron-doped diamond microtrench detector for flow injection analysisSpecial Issue. Testing the waters: a selection of papers from the first international multidisciplinary conference on detecting illicit drugs in wastewater.Comparing illicit drug use in 19 European cities through sewage analysis.N-nitrosodimethylamine (NDMA) formation during ozonation of dimethylamine-containing waters.Spatial and temporal occurrence of pharmaceuticals and illicit drugs in the aqueous environment and during wastewater treatment: new developments.The fate of pharmaceuticals and personal care products (PPCPs), endocrine disrupting contaminants (EDCs), metabolites and illicit drugs in a WWTW and environmental waters.The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.Drugs of abuse in wastewater and suspended particulate matter--further developments in sewage epidemiology.Illicit and pharmaceutical drug consumption estimated via wastewater analysis. Part A: chemical analysis and drug use estimates.Enantioselective transformation of fluoxetine in water and its ecotoxicological relevance.The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK.The effect of signal suppression and mobile phase composition on the simultaneous analysis of multiple classes of acidic/neutral pharmaceuticals and personal care products in surface water by solid-phase extraction and ultra performance liquid chrom
P50
Q28295260-F2D6EB00-4070-4E92-AFA2-FEBADF263B98Q30239884-2F67023D-EE61-46E1-9D2B-F4E58EC9161CQ30244453-B272A1B8-8323-44D2-B29A-8E21B0D37DA6Q31135493-6E5BFA2A-25A2-47B6-8CDB-F684F43830C9Q33419769-807C5C59-B5C7-4B2B-978D-F8C48D600A01Q33422713-C211066D-37A6-45D1-B90B-269BC5809913Q34376086-028CCE2E-D73C-40FE-B6C8-8AC2AABB068DQ35056826-4C9F6F07-F926-475C-9EC2-4771EF6B2726Q36183303-51B1D621-0C69-47A0-8DBB-E65DC56D50D7Q36224468-7E362C2A-5558-4C2D-A02C-0CDFDDC31C51Q37460828-EEEBA738-D1DE-4A94-8437-D7DF02752493Q37790280-A3BA56D7-2397-4052-A2F3-BB22643641D3Q37941953-92EEE0CB-42C8-45C0-A074-7AD2ED01C9F2Q38196603-881BCB5D-7434-4A40-99F5-4115EA8D1A3AQ38255406-43813DDF-B1EB-480C-9A1B-193678EB4DF8Q38300542-EDAEB13D-5E22-403D-B104-6C1F8D182DB7Q38430218-62108021-EBCC-4AE3-AD90-1C7FFAA625CFQ38761537-16B63649-6405-4B4D-90EE-51495E9EEA4EQ38834491-6DBF812D-C7E5-46EB-95C2-8933CAE802CBQ39170192-168AE710-3A49-432C-AEEB-FCC5F0E37373Q39524112-2022086B-4DC5-4372-9916-F3F47C5DBDBDQ39922791-33F6786F-0635-4F4D-AA43-4AC9A0BA03C9Q40081178-9FD5B67D-FC42-40CE-8B04-FDEA988DA203Q40082390-4DA1831E-C9CF-4939-B48E-17799F3D6E55Q40181991-F2403C35-6B10-4C4E-93D0-F2651D7FD9F9Q40374274-78D8A4A3-B468-47BA-872D-E72B707C8AA3Q40483173-7CC98A76-4FB5-4FD8-A033-8CA4435BB7EAQ40898351-ACA6829E-05DB-4F64-962D-26C2DAD123C1Q41848443-3C57FE1D-1878-4F61-83B7-B804C93D577EQ43316044-3BF21BEF-C6A3-4E15-8BE6-31271EDBC8FDQ43347266-4AFFBCB1-755A-40E2-B9F8-8AC9774A503CQ43352842-B46CC2C0-A9A1-42AF-9E14-EBF2A24ABB51Q43357142-44545431-35FF-4101-A624-0BDBC5C15434Q43359688-F1CCAFE6-268D-490E-A9B3-2EC6D1C102E0Q43366226-DABBE374-A243-4A41-8FD8-FEE28D1DA595Q44266465-92DC8B75-A48D-4FE5-B5D1-577FA6239128Q44909941-21886C9E-F331-4CD0-B4B6-00BBD79BE9D9Q44933833-727F10EB-83BA-4852-A12D-5EE1C21011B7Q46565663-3570C088-5FB2-416E-A762-A18BABA8C221Q46678119-C4CB7DFA-A4C3-4916-97F7-914386D921DF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Barbara Kasprzyk-Hordern
@ast
Barbara Kasprzyk-Hordern
@en
Barbara Kasprzyk-Hordern
@es
Barbara Kasprzyk-Hordern
@nl
type
label
Barbara Kasprzyk-Hordern
@ast
Barbara Kasprzyk-Hordern
@en
Barbara Kasprzyk-Hordern
@es
Barbara Kasprzyk-Hordern
@nl
prefLabel
Barbara Kasprzyk-Hordern
@ast
Barbara Kasprzyk-Hordern
@en
Barbara Kasprzyk-Hordern
@es
Barbara Kasprzyk-Hordern
@nl
P106
P1153
6506056329
P21
P31
P496
0000-0002-6809-2875